EUVIMEDEUVIMED entdecken
VergleichsstudieRandomisierte kontrollierte Studie

Onset of Action of Azelastine Nasal Spray Compared with Mometasone Nasal Spray and Placebo in Subjects with Seasonal Allergic Rhinitis Evaluated in an Environmental Exposure Chamber

Piyush Patel, Carrie D'Andrea, Harry J Sacks

American Journal of Rhinology · 2007-07 · 21 (4) · 499-503

DOI: 10.2500/ajr.2007.21.3058 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Rhinology, online erschienen am 01.07.2007. Verfasst von Piyush Patel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Allied Research International, Inc., Mississauga, Ontario, Canada. Hauptthemen laut MEDLINE: Atmosphere Exposure Chambers. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to determine the onset of action of azelastine hydrochloride nasal spray compared with placebo and an intranasal steroid, mometasone furoate, in subjects with seasonal allergic rhinitis (SAR).

Methods

Subjects with a history of SAR and symptomatic while exposed to ragweed pollen in an environmental exposure chamber (EEC) were randomized to azelastine nasal spray (n = 150), mometasone nasal spray (n = 150), or placebo (n = 150) and recorded total nasal symptom scores (TNSS), consisting of sneezing, nasal pruritus, rhinorrhea, and congestion, during an 8-hour study period.

Results

Azelastine nasal spray showed a statistically significant improvement in the TNSS at 15 minutes compared with placebo. The effect was durable at each time point during the 8-hour study. Azelastine nasal spray also was significantly more effective than mometasone at each time point.

Conclusion

Azelastine nasal spray has a rapid (15 minute) onset of action. Azelastine nasal spray was superior to both placebo and mometasone nasal spray in reducing nasal symptoms of SAR occurring within 8 hours after an allergen challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atmosphere Exposure ChambersAdolescentAdultAgedAnti-Allergic AgentsDouble-Blind MethodFemaleHumansMaleMiddle AgedMometasone FuroatePhthalazinesPregnadienediolsRhinitis, Allergic, SeasonalTime Factors

Substanzen

Anti-Allergic AgentsPhthalazinesPregnadienediolsMometasone Furoateazelastine

Autor:innen und Institutionen

  • Allied Research International, Inc., Mississauga, Ontario, Canada.

Zitieren

APA

Patel, P., D'Andrea, C., & Sacks, H. J. (2007). Onset of Action of Azelastine Nasal Spray Compared with Mometasone Nasal Spray and Placebo in Subjects with Seasonal Allergic Rhinitis Evaluated in an Environmental Exposure Chamber. American Journal of Rhinology, 21(4), 499-503. https://doi.org/10.2500/ajr.2007.21.3058

Vancouver

Patel P, D'Andrea C, Sacks HJ. Onset of Action of Azelastine Nasal Spray Compared with Mometasone Nasal Spray and Placebo in Subjects with Seasonal Allergic Rhinitis Evaluated in an Environmental Exposure Chamber. American Journal of Rhinology. 2007;21(4):499-503. doi:10.2500/ajr.2007.21.3058

BibTeX
@article{Patel2007,
  author = {Patel, Piyush and D'Andrea, Carrie and Sacks, Harry J},
  title = {Onset of Action of Azelastine Nasal Spray Compared with Mometasone Nasal Spray and Placebo in Subjects with Seasonal Allergic Rhinitis Evaluated in an Environmental Exposure Chamber},
  journal = {American Journal of Rhinology},
  year = {2007},
  volume = {21},
  number = {4},
  pages = {499--503},
  doi = {10.2500/ajr.2007.21.3058}
}
Kostenlos starten →